What's New

To access our newest articles, webinars, and podcasts, click on the item of interest to view or download.

Articles

The Keys to RTU Parenterals

In their September '09 article in PFQ (1st in a 3-part series), Baxter scientists Rao Chilamkurti and Paula Youngberg Webb discuss the challenges related to formulation development of ready-to-use products.

Pharmaceutical Formulation & Quality – Paula Youngberg Webb and Rao Chilamkurti, September 2009

Moving From Vials to Prefilled Syringes: A Project Manager's Perspective

Baxter's Raul Soikes discusses the complex issues involved in switching an injectable therapeutic's presentation from a liquid or lyophilized vial to a prefilled syringe and describes a potential regulatory strategy for getting the newly formatted drug to market.

Pharmaceutical Technology Supplement – Raul Soikes, September 2009

Baxter Blooms

Michael Borlet and Raul Soikes talk to Future Pharmaceuticals about the Bloomington facility and what sets BioPharma Solutions apart from other CMOs.

Future Pharmaceuticals – August 2009

Webinars

Shoot for Share: From Vial to Pre-Filled Syringe

According to recent estimates, the market for pre-filled systems is expected to top 2.4 billion by 2010. The increased interest in pre-filled syringes is in large part driven by the many advantages they offer to vials, including ease of use, reduced waste, improved dosing accuracy, and product differentiation.

Moving your drug from a vial to a pre-filled syringe offers market, customer, and product advantages. This complimentary webinar from Baxter BioPharma Solutions provides insight on:

  • Value proposition of moving to a pre-filled syringe
  • Regulatory planning to enable the move
  • Process to move from vial (liquid or lyophilized) to syringe
  • CMO qualifications needed

(June, 2009, Speaker - Raul Soikes, Sr. Director, Program Management, Baxter BioPharma Solutions)

"Second Sourcing – A Strategy to Mitigate Supply Chain Risk"

Supply chain risks are growing:

  • Less inventory slack
  • Longer supply lines
  • Greater exposure to global political and financial events

Industry experts Jim Miller of PharmSource and David Shuey of Willis HRH lead a discussion of pharma business risk and its' management in order to minimize the effects of risk on an organization's capital and earnings.

This complimentary webinar from Baxter BioPharma Solutions provides insight on:

  • Major risks in pharma supply chain
  • Quantifying risk exposure and mitigation costs
  • Practical considerations for second sourcing arrangements

(March, 2009, Speakers – Jim Miller, President, PharmSource; David Shuey, North American Practice Leader – Life Science, Willis HRH)

Podcasts

Michael Borlet and Raul Soikes talk to Future Pharmaceuticals about the Bloomington facility and what sets BioPharma Solutions apart from other CMOs.

Download Podcast